Cargando…

Pulmonary Lymphangitic Spread of Multiple Myeloma as Early Relapse after Autologous Stem Cell Transplantation

Clinical relapses early after autologous stem cell transplantation portrays an inferior clinical outcome. Early relapse in this setting with extramedullary disease (EMD) of lung involvement in multiple myeloma is rare. To our knowledge, this is the first reported case of lymphangitic spread of myelo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thapa, Bicky, Ahmed, Gulrayz, Mohan, Meera, Shponka, Volodymyr, Hari, Parameswaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041536/ https://www.ncbi.nlm.nih.gov/pubmed/33884207 http://dx.doi.org/10.1155/2021/5590975

Ejemplares similares

Relapsed breast adenorcarcinoma presenting as pulmonary lymphangitic carcinomatosis
por: Loh, KP, et al.
Publicado: (2012)

A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics
por: Awada, Hassan, et al.
Publicado: (2021)

SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING AFTER A PRIOR AUTOTRANSPLANT – REDUCED INTENSITY ALLOGENEIC VERSUS AUTOLOGOUS TRANSPLANTATION
por: Freytes, Cesar O., et al.
Publicado: (2013)

Prevalence and Significance of Sarcopenia in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
por: Williams, Alexis, et al.
Publicado: (2020)

Pulmonary lymphangitic carcinomatosis secondary to ureteral cancer
por: Sugimoto, Hiroshi, et al.
Publicado: (2021)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
por: Yarlagadda, Lakshmi, et al.
Publicado: (2021)

Pulmonary Lymphangitic Carcinomatosis due to Renal Cell Carcinoma
por: Guddati, Achuta K., et al.
Publicado: (2012)

Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
por: Meyer, Andrew, et al.
Publicado: (2012)

Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014
por: D’Souza, Anita, et al.
Publicado: (2017)

Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013)

Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Rodriguez, Tulio E., et al.
Publicado: (2016)

Pulmonary lymphangitic carcinomatosis from squamous cell carcinoma of the cervix
por: Kanthan, Rani, et al.
Publicado: (2010)

Delays in Diagnosis of Pulmonary Lymphangitic Carcinomatosis due to Benign Presentation
por: Pandey, Swati, et al.
Publicado: (2020)

Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes
por: Hari, P, et al.
Publicado: (2017)

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
por: Maffini, Enrico, et al.
Publicado: (2019)

Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time
por: Kumar, Shaji K, et al.
Publicado: (2017)

Excellent Response with Ado-Trastuzumab Emtansine in a Patient with Relapsed Metastatic Breast Cancer Presenting with Pulmonary Lymphangitic Carcinomatosis
por: Yu, Zhou, et al.
Publicado: (2017)

Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
por: Goswami, Chitrita, et al.
Publicado: (2019)

Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2022)

Pulmonary lymphangitic carcinomatosis with ground‐glass opacities as presentation of prostate cancer
por: Hibino, Makoto, et al.
Publicado: (2018)

Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
por: Yuan, Yuan, et al.
Publicado: (2009)

Lymphangitic papules caused by Nocardia takedensis
por: Chung, Esther, et al.
Publicado: (2015)

Zosteriform Lymphangitic Metastases of Eccrine Porocarcinoma
por: Zhang, Yunfang, et al.
Publicado: (2019)

Lymphangitic Carcinomatosis of Possible Urothelial Origin
por: Saini, Tanjot, et al.
Publicado: (2023)

P900: SALVAGE AUTOLOGOUS STEM CELL TRANSPLANT IN RELAPSED MULTIPLE MYELOMA: A SINGLE CENTRE EXPERIENCE
por: Duarte, S., et al.
Publicado: (2022)

Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era
por: Zhou, Huixing, et al.
Publicado: (2023)

Recent advances in understanding multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2016)

Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT
por: Drozd-Sokołowska, Joanna, et al.
Publicado: (2022)

A rare presentation of Pulmonary Lymphangitic Carcinomatosis in cancer of lip: case report
por: Babu, Sajith, et al.
Publicado: (2011)

Dramatic mixed response of lymphangitic pulmonary metastases in newly diagnosed prostate cancer
por: Gorshein, Elan, et al.
Publicado: (2017)

Pulmonary lymphangitic carcinomatosis from gallbladder cancer mimicking diffuse alveolar haemorrhage
por: Higo, Hisao, et al.
Publicado: (2020)

Prognosis of pulmonary lymphangitic carcinomatosis in patients with non-small cell lung cancer
por: Im, Yunjoo, et al.
Publicado: (2021)

Successful Treatment of Gastric Relapse in Multiple Myeloma with Bortezomib after Autologous Hematopoietic Stem Cell Transplantation (autoHSCT)
por: Sivgin, Serdar, et al.
Publicado: (2013)

Isolated central nervous system relapse of multiple myeloma post autologous stem cell transplant- A rare presentation
por: Mittal, Abhenil, et al.
Publicado: (2020)

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma
por: Baertsch, Marc-Andrea, et al.
Publicado: (2021)

Current status of autologous stem cell transplantation for multiple myeloma
por: Al Hamed, Rama, et al.
Publicado: (2019)

Acute kidney injury associated with lymphangitic carcinomatosis
por: Sannier, Aurélie, et al.
Publicado: (2018)

Risk of relapse of multiple myeloma following kidney transplantation
por: Shah, Sapna, et al.
Publicado: (2019)

Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
por: Hammons, Lindsay R., et al.
Publicado: (2022)

Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j8pi2n8qimephafi1frt742a6e